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Background: Previous studies have demonstrated that postprandial hyperglycemia attenuates brachial artery
flow-mediated dilation (FMD) in prediabetic patients, in diabetic patients, and even in normal subjects. We have
previously reported that postprandial hyperinsulinemia also attenuates FMD. In the present study we evaluated the
relationship between different degrees of postprandial attenuation of FMD induced by postprandial hyperglycemia
and hyperinsulinemia and differences in ingested carbohydrate content in non-diabetic individuals.
Methods: Thirty-seven healthy subjects with no family history of diabetes were divided into 3 groups: a 75-g oral
glucose loading group (OG group) (n = 14), a test meal group (TM group) (n = 12; 400 kcal, carbohydrate content
40.7 g), and a control group (n = 11). The FMD was measured at preload (FMD0) and at 60 minutes (FMD60) and
120 (FMD120) minutes after loading. Plasma glucose (PG) and immunoreactive insulin (IRI) levels were determined
at preload (PG0, IRI0) and at 30 (PG30, IRI30), 60 (PG60, IRI60), and 120 (PG120, IRI120) minutes after loading.
Result: Percentage decreases from FMD0 to FMD60 were significantly greater in the TM group (−21.19%± 17.90%;
P < 0.001) and the OG group (−17.59%± 26.64%) than in the control group (6.46%± 9.17%; P < 0.01), whereas no
significant difference was observed between the TM and OG groups. In contrast, the percentage decrease from
FMD0 to FMD120 was significantly greater in the OG group (−18.91%± 16.58%) than in the control group
(6.78%± 11.43%; P < 0.001) or the TM group (5.22%± 37.22%; P < 0.05), but no significant difference was observed
between the control and TM groups. The FMD60 was significantly correlated with HOMA-IR (r =−0.389; P < 0.05). In
contrast, FMD120 was significantly correlated with IRI60 (r =−0.462; P < 0.05) and the AUC of IRI (r =−0.468; P < 0.05).
Furthermore, the percentage change from FMD0 to FMD120 was significantly correlated with the CV of PG
(r = 0.404; P < 0.05), IRI60 (r = 0.401; p < 0.05) and the AUC of IRI (r = 0.427; P < 0.05). No significant correlation was
observed between any other FMDs and glucose metabolic variables.
Conclusion: Differences in the attenuation of postprandial FMD induced by different postprandial insulin levels
may occur a long time postprandially but not shortly after a meal.
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Postprandial hyperglycemia is a major risk factor for
morbidity and mortality from cardiovascular disease in
diabetes [1,2]. Furthermore, in prediabetes, the postpran-
dial glucose level, but not the impaired fasting glucose
tolerance, is an independent risk factor for cardiovascu-
lar disease [3]. Postprandial hyperglycemia is independ-
ently related to the risk of cardiovascular disease in
patients with prediabetes or diabetes. Furthermore, in
these patients postprandial hyperglycemia is more
strongly related to the progression of atherosclerosis
than is fasting hyperglycemia [4]. Vascular endothelial
dysfunction plays an important early role in atheroscler-
osis [5] and can be assessed by measuring flow-mediated
dilation (FMD) of the brachial artery with ultrasonog-
raphy during reactive hyperemia [6,7]. Attenuation of
brachial artery FMD is induced by postprandial hyper-
glycemia in subjects with normal glucose tolerance and
in prediabetic or diabetic patients, and FMD is nega-
tively correlated with plasma glucose (PG) levels after
oral glucose loading [8-11]. We have previously reported
that postprandial hyperinsulinemia also induces attenu-
ation of FMD in persons with normal glucose tolerance
[12]. Several studies have evaluated differences in FMD
attenuation after meals with different carbohydrate con-
tents [13-17]. Although these studies have found that
the attenuation of postprandial FMD is affected by post-
prandial lipid metabolism [14-17], how it is affected by
glucose metabolism after meals with different carbohy-
drate contents remains unclear.
Therefore, in the present study, we evaluated differ-
ences in the attenuation of postprandial FMD induced
by postprandial hyperglycemia and hyperinsulinemia
after the intake of meals with different carbohydrate
contents in non-diabtetic subjects.
Methods
Study subjects
Thirty-seven healthy Japanese volunteers aged 22 to
61 years (19 men and 18 women; mean age,
31.8 ± 9.2 years) with no family history of diabetes were
recruited. Before enrollment, written informed consent
was obtained from all subjects. All subjects underwent
medical checkups and denied a history of dyslipidemia,
diabetes mellitus, hypertension, or other chronic dis-
eases. Normal glucose tolerance was defined as a fasting
PG level of <6.1 mmol/L and a 2-hour value of
<7.8 mmol/L on the 75-g oral glucose loading test, on
the basis of the Report of the Committee on the Classifi-
cation and Diagnostic Criteria of Diabetes Mellitus of
the Japanese Diabetes Society [18]. Normal blood pres-
sure was defined as a blood pressure of <140/90 mmHg
that was measured in a hospital, on the basis of the Japa-
nese Society of Hypertension Committee for Guidelinesfor the Management of Hypertension [19]. Normal lipid
metabolism was defined as low-density lipoprotein chol-
esterol (LDL-C) level of <140 mg/dL (3.63 mmol/L), a
high-density lipoprotein cholesterol (HDL-C) level
of ≥ 40 mg/dL (1.04 mmol/L), and a triglyceride (TG)
level <150 mg/dL (1.70 mmol/L), on the basis of the Ex-
ecutive Summary of Japan Atherosclerosis Society
Guideline for Diagnosis and Prevention of Atheroscler-
otic Cardiovascular Disease of Japanese [20].
Study design
The study was designed in compliance with the ethics
regulations set out by the Helsinki Declaration. Report-
ing of the study conforms to the STROBE (Strengthen-
ing the Reporting of Observational Studies in
Epidemiology) guidelines, along with references to
STROBE and the broader EQUATOR (Enhancing the
Quality and Transparency of Health Research)
guidelines.
The 37 study subjects were divided into 3 groups on
the basis of carbohydrate intake: (1) a test meal group
(TM group) (intake = 40.7 g of carbohydrates, 400 kcal;
n = 12), (2) a 75-g oral glucose load group (OG group)
(intake = 75 g of carbohydrates, 300 kcal; n = 14), and (3)
an overnight fasting group (control group) (n = 11)
(Table 1). The subjects of the OG and control groups
had previously been included in our study of postpran-
dial attenuation of FMD [12]. The test meal for the TM
group (Table 2) was a commercial energy-supplement
food (CalorieMateW, Otsuka Pharmaceutical Co., Ltd.,
Tokyo, Japan). The subjects’ baseline clinical characteris-
tics and biochemical variables, including glucose meta-
bolic variables, were evaluated at 9 a.m. after at least
12 hours of overnight fasting. The glucose metabolic
variables selected were PG levels and plasma immunor-
eactive insulin (IRI) levels. The PG and IRI levels of all
groups after overnight fasting were defined as PG0 and
IRI0, respectively. After the biochemical variables had
been evaluated after overnight fasting, the subjects of
the OG group ingested 75 g of glucose, and the TM
group ingested the test meal with 500 ml of water within
10 minutes. The PG and IRI levels in the OG and TM
groups were then evaluated at 30 (PG30 and IRI30), 60
(PG60 and IRI60), and 120 minutes (PG120 and IRI120)
after loading. The area under the curve (AUC) and the
coefficient of variation (CV) of the PG or IRI level were
determined from 4 measurement points. The FMD of
the right brachial artery was evaluated by means of A-
and B-mode ultrasonography with a 10-MHz linear-
array transducer (UNEXEF18G, UNEX Corp., Nagoya,
Japan). This transducer can accurately capture the target
artery from 3 directions and can continuously measure
the FMD of the same position with B-mode ultrasound
images. For the hyperemia scan, the conduit artery was
Table 1 Clinical characteristics of subjects of the 3 groups
Clinical characteristic Control group (n = 11) TM group (n= 12) OG group (n = 14)
Sex (men) 7 (63.6) 6 (50.0) 6 (42.9)
Age (years) 33.4 ± 8.4 28.5 ± 5.1 33.4 ± 11.9
BMI (kg/m2) 21.94 ± 1.88 22.53 ± 2.46 20.71 ± 2.28
Smoking habits
None 6 (54.5) 10 (83.3) 5 (35.7)
Recent 2 (18.2) 2 (16.7) 6 (42.9)
Current 3 (27.3) 0 (0) 3 (21.4)
Family history of diabetes 0 (0) 0 (0) 0 (0)
Blood pressure (mm Hg)
Systolic 104.8 ± 5.2 115.9 ± 11.5* 105.5 ± 8.5
Diastolic 61.5 ± 7.0 71.2 ± 9.1* 64.3 ± 6.4
TC (mmol/L) 4.55 ± 0.58 4.46 ± 0.61 4.95 ± 0.61
HDL-C (mmol/L) 1.46 ± 0.26 1.63 ± 0.37 1.73 ± 0.42
LDL-C (mmol/L) 2.62 ± 0.50 2.39 ± 0.36 2.74 ± 0.54
TG (mmol/L) 0.99 ± 0.34 0.66 ± 0.29# 0.82 ± 0.35
Uric acid (μmol/L) 294.4 ± 36.7 323.2 ± 109.4 315.9 ± 100.6
Serum creatinine (μmol/L) 62.12 ± 13.07 61.00 ± 8.22 65.54 ± 14.11
Fasting PG (mmol/L) 5.09 ± 0.54 4.75 ± 0.62 4.79 ± 0.58
IRI (pmol/L) 38.70 ± 16.35 30.67 ± 13.63 32.71 ± 16.94
HOMA-IR 1.18 ± 0.75 0.92 ± 0.52 1.07 ± 0.73
HbA1C (%) 5.40 ± 0.21 5.21 ± 0.29 5.37 ± 0.26
mean± SD, n (%).
TM: test meal, OG: 75-g oral glucose loading.
*P < 0.05 for TM group vs control and OG groups, #P < 0.05 for TM group vs control group.
FPG: fasting plasma glucose. IRI: immunoreactive insulin. HOMA-IR: homeostasis model assessment of insulin resistance.
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tion. For FMD measurements with the transducer, the
interobserver correlation coefficient was r = 0.961
(P < 0.001), and the intraobserver variability was 2.4%.
The subjects were instructed to abstain from smoking
and caffeine consumption for at least 8 hours before the
start of the study and to lie down for 15 minutes. The
FMD was measured according to a report of the Inter-
national Brachial Artery Reactivity Task Force [6]. The
baseline diameter of the brachial artery was defined as
its mean diameter 5 cm proximal to the elbow joint dur-
ing 4 consecutive diastoles on an electrocardiogram be-
fore hyperemia. After this baseline diameter had been
determined, forearm hyperemia was produced with
sphygmomanometric cuff inflation to 50 mmHg greater
than the systolic blood pressure for 5 minutes. After the
cuff had been deflated, the maximum diameter of the
brachial artery after hyperemia was measured. The rate
of change in diameter (%) determined from the max-
imum diameters at baseline and after hyperemia was
defined as the FMD. The FMDs of the OG and TM
groups determined at preload were designated FMD0s,
and those measured 60 and 120 minutes after loadingwere designated FMD60s and FMD120s, respectively. In
the control group FMDs were measured 3 times at 1-
hour intervals after the overnight fast and designated
FMD0, FMD60, and FMD120.
To evaluate differences in how FMD changed among
the 3 groups, the percentage change from FMD0 to
FMD 60 was calculated as 100 × (FMD60-FMD0)/FMD0,
and the change from FMD0 to FMD120 was calculated
as 100 × (FMD120-FMD0)/FMD0. To evaluate the corre-
lations between changes in FMD and glucose metabolic
variables, the percentage changes in FMD in the 3
groups were calculated as follows: ΔF1%= 100 × (FMD0-
FMD60)/FMD0, and ΔF2%= 100 × (FMD0-FMD120)/
FMD0.
Clinical characteristics
After overnight fasting, the clinical characteristics of the
subjects were evaluated. These characteristics included
sex, age, body-mass index (BMI), smoking habit, family
history of diabetes, systolic and diastolic blood pressures,
and biochemical variables, including serum total choles-
terol (TC), LDL-C, HDL-C, TG, PG, IRI, and HbA1C.
Serum TC, LDL-C, HDL-C, and TG were measured with
Table 2 Meal composition, glucose metabolism variables, and FMD of the three groups
Variables Control group (N=11) TM group (N= 12) OG group (N= 14)
(1) Meal composition
Carbohydrate content (g) 0 40.7 75
Lipid content (g) 0 22.2 0
Total calorie (kcal) 0 400 300
(2) Glucose metabolism variables
Plasma glucose (mmol/L)
0 min. 5.16 ± 0.42 4.71 ± 0.37* 4.65 ± 0.43*
30 min. n/a 5.41 ± 0.97 6.83 ± 1.84#
60 min. n/a 5.16 ± 1.07 6.07 ± 1.61
120 min. n/a 5.28 ± 0.39 5.05 ± 1.13
AUC of PG [(mmol/L)hr] n/a 10.39 ± 1.32 11.66 ± 2.21
CV of PG n/a 0.12 ± 0.06 0.25 ± 0.10##
Plasma IRI (pmol/L)
0 min. n/a 34.16 ± 18.6 29.67 ± 11.95
30 min. n/a 204.25 ± 61.65 278.08 ± 109.28#
60 min. n/a 144.86 ± 82.76 281.11 ± 155.48##
120 min. n/a 76.00 ± 38.32 138.53 ± 62.33#
AUC of IRI [(pmol/L)hr] n/a 257.31 ± 87.04 426.55 ± 126.73##
CV of IRI n/a 0.73 ± 0.17 0.88 ± 0.22
(3) FMD (%)
FMD0 9.93 ± 3.97 11.98 ± 5.53 9.16 ± 1.85
FMD60 10.43 ± 3.71 9.10 ± 3.97 7.53 ± 2.98*
FMD120 10.46 ± 3.73 11.83 ± 5.04 7.46 ± 2.28#*
mean± SD.
*p< 0.05 vs. Control group, #p< 0.05, ##p< 0.01 vs TM group.
PG: plasma glucose. IRI: immunoreactive insulin. AUC: area under the curve.
CV: coefficient of variation. FMD: flow-mediated dilation. FMD0, FMD60,
and FMD 120: FMD at pre-load, 60 minutes, and 120 minutes after meal loading.
n/a: not available.
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the glucose oxidase method. The plasma IRI level was
measured with a radioimmunoassay, and HbA1C (Japan
Diabetes Society: JDS) was measured with high-
performance liquid chromatography (JDS Lot 3 calibra-
tion). The HbA1c (JDS) was converted into HbA1c
(NGSP), so that HbA1c (JDS) + 0.4 became equal to
HbA1c (NGSP) (%) [21].Statistical analysis
The Mann–Whitney U-test was used to compare differ-
ences in clinical characteristics and FMD among the 3
groups. The Wilcoxon test was used to compare differ-
ences in the mean values of FMD0, FMD60, and
FMD120. Pearson’s correlation coefficients were used to
evaluate correlations between FMD and glucose meta-
bolic variables. Data are presented as means ± SD. Statis-
tical significance was indicated by P < 0.05. All analyseswere performed with SPSS for Windows Ver. 12.0 J
(SPSS Japan Inc).
Results
The TG levels in the TM group were significantly lower
than those in the control group, but no significant differ-
ences in other clinical characteristics were observed
among the 3 groups (Table 1).
The PG level in the OG group (Table 2, Figure 1A)
increased markedly during the first 30 minutes after
loading but had returned to baseline by 120 minutes. In
the TM group, however, PG increased slightly in the first
30 minutes after meal ingestion, then decreased slightly,
and finally increased slightly again between 60 and
120 minutes. The PG30 was significantly higher in the
OG group than in the TM group, and no significant cor-
relation was observed at any other time. The IRI in the
TM group (Table 2, Figure 1B) increased markedly in
the first 30 minutes after meal ingestion and then
Figure 1 Changes in PG (A), IRI (B), and FMD (C) in the TM, OG, and control groups. #P < 0.05, ## P < 0.01 vs. PG or IRI in the TM group,
€P < 0.05 vs. FMD0 in the OG group, $P < 0.01 vs. FMD0 and FMD120 in the TM group,*P < 0.05 vs. FMD60 of the control group, \P < 0.05 vs.
FMD120 in the TM and control groups.
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similar pattern, but the peak was somewhat delayed. The
IRI30, IRI60, and IRI120 were all significantly higher in
the OG group than in the TM group. The CV of PG and
the AUC of IRI were significantly higher in the OG
group than in the TM group. However, neither the AUC
of PG nor the CV of the IRI differed significantly be-
tween the OG and TM groups (Table 2).
The FMDs in the control group did not differ signifi-
cantly from each other (Table 2, Figure 1C). In the TM
group, however, FMD60 was significantly lower than
FMD0 (P < 0.01), but FMD120 did not differ significantly
from FMD0. In the OG group, both FMD60 and FMD
120 were significantly lower than FMD0 (both P < 0.05).
The percentage decrease from FMD0 to FMD60 in the
TM group (−21.19%± 17.90%, P < 0.001) and in the OG
(−17.59%± 26.64%, P < 0.01) group was significantly
greater than that in the control group (6.46 ± 9.17%) but
did not differ significantly between the TM group and
the OG group (Figure 2). In contrast, the percentage de-
crease from FMD0 to FMD120 was significantly greater
in the OG group (−18.91%± 16.58%) than in the control
group (6.78%± 11.43%, P < 0.001) or in the TM group
(5.22%± 37.22%, P < 0.05) but did not differ significantly
between the control group and the TM group.
An analysis of FMD0 and glucose metabolic variables
showed no significant correlation in either the TM group
or the OG group (Table 3). However, significant correla-
tions were found of FMD60 with the homeostasis model
assessment of insulin resistance (HOMA-IR) and of
FMD120 with IRI60 and with the AUC of IRI. No sig-
nificant correlation was observed between ΔF1% and
glucose metabolic variables, but ΔF2% was significantly
correlated with the CV of PG (r = 0.404; P = 0.041), IRI60
(r = 0.401; P = 0.042), and the AUC of IRI (r = 0.427;
P = 0.03).Discussion
The present study has demonstrated attenuation of post-
prandial FMD, both after ingestion of a test meal and
after oral glucose loading, which was correlated with
variables of glucose metabolism. However, the relation-
ship between the postprandial FMD attenuation and glu-
cose metabolic variables differed between the ingestion
of a test meal and oral glucose loading.
Although PG and IRI levels in the OG group were
higher than those in the TM group, the FMD60 was simi-
lar in both groups. The FMD60 was correlated only with
the HOMA-IR, and no significant association was found
between HOMA-IR and FMD120. In fact, the change
from FMD0 to FMD60 did not differ significantly between
the TM group and the OG group. These results suggest
that insulin resistance is associated with short-term, but
not long-term, attenuation of vascular endothelial func-
tion both after test meal ingestion and after oral glucose
loading. Oral antidiabetic agents, such as pioglitazone, that
decrease insulin resistance also improve endothelial func-
tion in patients with diabetes [22] or impaired glucose tol-
erance [23]. Improvement of fasting FMD is correlated
with improvement of insulin resistance [24]. The brachial
artery FMD is correlated with the euglycemic hyperinsuli-
nemic glucose clamp-derived glucose metabolic clearance
rate in normotensive first-degree relatives of patients with
type 2 diabetes [25]. We speculate that the delay in glu-
cose metabolic clearance in patients with insulin resist-
ance induces greater attenuation of postprandial FMD in
subjects with insulin resistance than in subjects with nor-
mal insulin sensitivity.
In contrast, although FMD showed a continuous de-
crease in the OG group, it did not decrease in the TM
group during study period. The change in FMD from 0 to
120 minutes after loading was significantly correlated with

























Figure 2 Percentage changes in FMD in the control, TM, and OG groups. From FMD0 to FMD 60: 100× (FMD60-FMD0)/FMD0. From
FMD0 to FMD120: 100× (FMD120-FMD0)/FMD0. TM group: test meal group, OG group: 75-g oral glucose loading group.
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the magnitude of elevation and fluctuation of both post-
prandial PG and IRI. Endothelial dysfunction in diabetes
has been attributed to elevated oxidative stress levels
induced by several mechanisms, especially abnormalities
in glucose metabolism [26]. In fact, endothelial dysfunc-
tion is improved by oral antidiabetic agents in patients
with type 2 diabetes [22,27-29]. These agents ameliorate
abnormalities in glucose metabolism and, as a result, re-
duce oxidative stress in patients with diabetes. Both FMDTable 3 Correlations between FMD and glucose metabolism v





AUC of PG −0.182 0.00





AUC of IRI [(mmol/L)hr] −0.253 −0.07
CV of IRI [(pmol/L)hr] −0.220 −0.30
HOMA-IR −0.297 −0.38
*P < 0.05.
PG30, PG60, and PG120: plasma glucose at 30, 60, and 120 minutes after meal load
IRI30, IRI60, and IRI120: immunoreactive insulin 30, 60, and 120 minutes after meal
ΔF1%: 100 × (FMD0-FMD60)/FMD0. ΔF2%: 100 × (FMD0-FMD120)/FMD0.
HOMA-IR: homeostasis model assessment of insulin resistance.and PG levels are significantly correlated with plasma
levels of thiobarbituric acid reactive substances during oral
glucose tolerance testing in subjects with normal glucose
tolerance who have first-degree relatives with type 2 dia-
betes [9] and in subjects with impaired glucose tolerance
[10]. Acarbose, nateglinide, and mitiglinide have been
reported to decrease postprandial hyperglycemia and to
improve endothelial function in patients with type 2 dia-
betes [27,30,31] and in patients with impaired glucose tol-
erance [32]. Furthermore, repetitive fluctuations in PG orariables of TM and OG groups
0 FMD120 ΔF1% ΔF2%
5 −0.281 −0.101 0.279
2 −0.221 −0.251 0.295
5 0.154 −0.032 −0.060
2 −0.222 −0.194 0.264
0 −0.323 0.047 0.404*
1 −0.238 0.021 0.197
8 −0.438* −0.250 0.401*
7 −0.145 −0.306 0.236
9 −0.460* −0.247 0.427*
6 −0.315 0.035 0.147
9* −0.234 0.189 −0.139
ing.
loading.
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endothelium of the rat thoracic aorta, and stable hypergly-
cemia or hyperinsulinemia has been found to cause less
monocyte adhesion than does repetitive PG fluctuation
[33]. These previous findings and the results of our
present study suggest that the difference in oxidative stress
induced by the difference in postprandial hyperglycemia
between the TM and OG groups caused the difference in
attenuation of FMD120 in our subjects with normal glu-
cose tolerance.
Our study has also demonstrated that the attenuation
of postprandial FMD is significantly associated with
plasma insulin levels in subjects with normal glucose tol-
erance. Plasma insulin is generally considered to have a
beneficial effect on vascular endothelial function [34]. In
contrast, insulin resistance reduces the bioavailability of
endothelial nitric oxide. Insulin resistance decreases the
number of endothelial progenitor cells and hinders the
vascular repair induced by disturbed PI3K/AKt signaling,
reactive oxygen species, inflammation, and adipokines
[35]. The continuous infusion of insulin with an euglyce-
mic or hyperglycemic clamp causes attenuation of fem-
oral and brachial artery endothelium-dependent
vasodilation 4 hours after baseline, and attenuation of
FMD induced by insulin is inhibited by the addition of
an antioxidant agent (vitamin C) [36]; however,
endothelium-independent vasodilation is not attenuated
by insulin. These findings suggest that a high plasma
level of insulin in the postprandial state attenuates post-
prandial FMD and delays the recovery of FMD after ab-
sorption of PG.
Our study had several limitations. First, we could not
evaluate the effect of postprandial lipid metabolism on
postprandial FMD. We had concluded that the effect of
22 g of fat in the meal ingested by the TM group could
be ignored. Accordingly, we measured FMD from base-
line to 120 minutes after loading following the method
of Lavi et al. [13]. However, several studies have shown
that postprandial attenuation of FMD induced by fat
lasts for more than 120 minutes after fat loading [15,16].
Therefore, a study measuring postprandial FMD for
more than 120 minutes after loading is needed to clarify
the effects of dietary fat intake observed in the present
study. Second, Major-Pedersen et al. have reported, in
contrast with our present results, that oral glucose does
not induce endothelial dysfunction in healthy persons
with mean insulin and PG values of 5.6 mmol/L and
27.2 mmol/L, respectively, 2 hours after a glucose load
[37]. However, the study of Major-Petersen et al. and the
present study differ in the methods of FMD measure-
ment and the characteristics of subjects. For example,
the effects of reactive hyperemia on the sympathetic
nerve might differ because Major-Petersen et al. used a
sphygmomanometric cuff pressure that was higher(300 mm Hg) than the pressure we used (systolic blood
pressure + 50 mm Hg). Also, the subjects of Major-
Petersen et al. might have been healthier than ours because
they had a lower mean fasting PG level. Furthermore,
the peak PG and IRI levels that induced postprandial
attenuation of FMD might have appeared less than
30 minutes after loading because the mean age of sub-
jects in our TM group was 28.5 years [38]. Therefore,
the conflicting results between the present study and
the study of Major-Petersen et al. might be attributed
to these differences. Third, we could not assess the re-
lationship between oxidative stress and FMD in our
subjects. It is necessary to evaluate the effects of post-
prandial lipid metabolism, heart rate, blood pressure,
and oxidative stress on postprandial FMD. Fourth, the
study population of our study was a composite group
with a wide range of PG and IRI levels, whereas our
study subjects had been identified with medical check-
ups to have normal glucose tolerance. A cross-over
study should be performed to resolve these problems.
Finally, because the number of subjects in the present
study was small, our results should be clarified with a
larger number of subjects.
In summary, our study suggests that attenuation of bra-
chial artery FMD in the postprandial state is correlated
with postprandial glucose fluctuation, insulin resistance,
and the postprandial serum insulin level in non-diabetic
individuals. Furthermore, differences in the attenuation of
postprandial vascular endothelial function induced by dif-
ferent postprandial insulin levels may occur a long time
postprandially but not shortly after a meal.
Further longitudinal studies are necessary in subjects
with normal glucose tolerance to investigate the long-term
effects of postprandial glucose metabolism on endothelial
function and the possible contribution of this endothelial
dysfunction to the development of atherosclerosis.Abbreviations
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